$49.880
-0.160 (-0.32%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CRSP por análisis de gráficos similares
Alphio's CRSP stock price prediction model matches the current CRISPR Therapeutics AG tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $50.81 (+1.86%). The 1-week path is $53.54 (+7.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de CRISPR Therapeutics AG?
CRISPR Therapeutics AG is not a good buy right now due to its current price of $49.25, a significantly low RSI of 33.306 indicating oversold conditions, and a troubling year-to-date change of -8.41%. The company is facing substantial losses, with a net income of -91154000 USD in Q2 2026 and a forward P/E ratio of 23.3645, suggesting overvaluation relative to its earnings potential. The main risk is insider selling, which has increased by 476.16% over the last month, indicating a lack of confidence from those closest to the company.
CRSP cerró en $49.88 el Tuesday, tras bajar -0.32%
CRISPR Therapeutics AG (CRSP) last closed at $49.88, losing -0.32%. These facts feed the 1-day and 1-week CRSP price prediction above.
Consenso de analistas
CRISPR Therapeutics AG (CRSP): 3 comprar, 3 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de CRISPR Therapeutics AG (CRSP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CRSP, ordenadas por similitud.
Análisis de estacionalidad de CRSP
Historically the probability of a positive October return for CRSP is 44.26%. March offers the highest probability of a positive month at 61.90%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CRSP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $17.82 | $33.96 | $51.74 | -31.92% |
| Nov 2026 | $29.09 | $38.88 | $44.05 | -22.05% |
| Dec 2026 | $37.57 | $46.16 | $57.97 | -7.46% |
En 2026, se proyecta que CRISPR Therapeutics AG (CRSP) oscile entre $17.82 y $57.97.
Previsión mensual de CRISPR Therapeutics AG para 2026
En Oct de 2026, se proyecta que CRISPR Therapeutics AG promedie $33.96, con un mínimo de $17.82 y un máximo de $51.74.
En Nov de 2026, se proyecta que CRISPR Therapeutics AG promedie $38.88, con un mínimo de $29.09 y un máximo de $44.05.
En Dec de 2026, se proyecta que CRISPR Therapeutics AG promedie $46.16, con un mínimo de $37.57 y un máximo de $57.97.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.